Change of Adviser

RNS Number : 9140Z

Allergy Therapeutics PLC

16 December 2014

 



16 December 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Change of Adviser

Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces the appointment, with immediate effect, of Panmure Gordon (UK) Limited as its Nominated Adviser and Broker.

-Ends-

For further information

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite Finance Director
Panmure Gordon	[phone]
Freddy Crossley / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
FTI Consulting	[phone]
Simon Conway
Victoria Foster Mitchell

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.  Ithas a growing business achieving revenue in thelast financial yearof £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.  The Company is expanding its infrastructure into theEmerging markets.

 

END

 

 

APPKMMMZZVZGDZM